Ayeisha Milligan Armstrong still remembers the moment the data revealed a pattern no one had quite seen before: people with certain variants of the AQP4 gene who slept less than six hours a night were losing gray matter faster than their peers—while others with the same gene variants but longer sleep showed no such decline. At Edith Cowan University’s Centre for Precision Health, this discovery is reshaping how scientists think about Alzheimer’s risk, not as a fixed genetic fate, but as a dynamic interplay between DNA and daily habits. The study, published in Alzheimer’s & Dementia, examined 13 common variants of the aquaporin-4 (AQP4) gene, a key regulator of the brain’s fluid flow and its overnight waste-clearance system, which flushes out proteins like amyloid-beta linked to Alzheimer’s. For years, researchers have known poor sleep correlates with higher Alzheimer’s risk, but this research shows the connection runs deeper—genes and sleep habits actively modify each other’s effects on the brain.
The team analyzed self-reported sleep patterns, brain scans, and cognitive performance in a cohort of older adults, tracking how brain structure and function changed over time. They found that shorter sleep duration—particularly under six hours—was associated with accelerated gray matter loss in individuals carrying specific AQP4 variants. Others who took longer to fall asleep showed structural brain changes tied to reduced volume, a potential early marker of neurodegeneration. Even more striking, cognitive performance over time varied depending on both sleep quality and genetic makeup: some variants appeared protective with good sleep, while becoming detrimental with poor sleep. This means the same gene can act as a shield or a vulnerability, depending on lifestyle.
“This moves us closer to understanding why some people decline faster than others, even when they have similar risk on paper,” said Professor Simon Laws, Director of the Centre for Precision Health. The findings underscore a shift toward precision prevention—moving away from one-size-fits-all advice and toward tailored interventions. While the researchers don’t recommend genetic testing yet, they call for larger, more diverse studies and genetics-informed clinical trials to test whether improving sleep can neutralize genetic risk. If confirmed, such trials could lead to personalized sleep recommendations for Alzheimer’s prevention, offering a powerful, accessible tool long before symptoms arise. As Dr. Tenielle Porter puts it, “A more targeted and personalized approach to Alzheimer’s prevention may be needed.” In the quiet hours of the night, when the brain’s cleaning system hums to life, science is learning that how we sleep may be one of the most important choices we make—for our genes are not our destiny, but partners in the rhythm of our daily lives.